These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16439879

  • 21. Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
    Wood E, Hogg RS, Lima VD, Kerr T, Yip B, Marshall BD, Montaner JS.
    JAMA; 2008 Aug 06; 300(5):550-4. PubMed ID: 18677027
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
    Long EF, Brandeau ML, Galvin CM, Vinichenko T, Tole SP, Schwartz A, Sanders GD, Owens DK.
    AIDS; 2006 Nov 14; 20(17):2207-15. PubMed ID: 17086061
    [Abstract] [Full Text] [Related]

  • 23. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000.
    Lai DJ, Tarwater PM, Hardy RJ.
    Public Health; 2006 Jun 14; 120(6):486-92. PubMed ID: 16730037
    [Abstract] [Full Text] [Related]

  • 24. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B.
    Clin Infect Dis; 2009 Nov 01; 49(9):1433-40. PubMed ID: 19807275
    [Abstract] [Full Text] [Related]

  • 25. Validity of self-reported adherence among injection drug users.
    Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E.
    J Int Assoc Physicians AIDS Care (Chic); 2008 Nov 01; 7(4):157-9. PubMed ID: 18626123
    [Abstract] [Full Text] [Related]

  • 26. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population.
    Ormaasen V, Sandvik L, Dudman SG, Bruun JN.
    Scand J Infect Dis; 2007 Nov 01; 39(1):51-7. PubMed ID: 17366013
    [Abstract] [Full Text] [Related]

  • 27. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 01; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 28. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, Mntambo M, Thomas M, Nixon K, Holst HL, Karim QA, Rollins NC, Coovadia HM, Giddy J.
    BMC Pediatr; 2007 Mar 17; 7():13. PubMed ID: 17367540
    [Abstract] [Full Text] [Related]

  • 29. Health related quality of life among both current and former injection drug users who are HIV-infected.
    Préau M, Protopopescu C, Spire B, Sobel A, Dellamonica P, Moatti JP, Carrieri MP, MANIF-2000 Study Group.
    Drug Alcohol Depend; 2007 Jan 12; 86(2-3):175-82. PubMed ID: 16930864
    [Abstract] [Full Text] [Related]

  • 30. Drug injection cessation among HIV-infected injecting drug users.
    Bouhnik AD, Carrieri MP, Rey D, Spire B, Gastaut JA, Gallais H, Obadia Y, MANIF 2000 Study Group.
    Addict Behav; 2004 Aug 12; 29(6):1189-97. PubMed ID: 15236822
    [Abstract] [Full Text] [Related]

  • 31. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
    Michel L, Giorgi R, Villes V, Poizot-Martin I, Dellamonica P, Spire B, Protopopescu C, Carrieri MP.
    Drug Alcohol Depend; 2009 Jan 01; 99(1-3):96-104. PubMed ID: 18774237
    [Abstract] [Full Text] [Related]

  • 32. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E.
    AIDS; 2006 May 12; 20(8):1181-9. PubMed ID: 16691070
    [Abstract] [Full Text] [Related]

  • 33. Directly observed antiretroviral therapy for injection drug users with HIV infection.
    Clarke S, Keenan E, Ryan M, Barry M, Mulcahy F.
    AIDS Read; 2002 Jul 12; 12(7):305-7, 312-6. PubMed ID: 12161852
    [Abstract] [Full Text] [Related]

  • 34. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L, Marazzi MC, Voetberg A, Magid NA.
    AIDS; 2007 Jul 12; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [Abstract] [Full Text] [Related]

  • 35. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.
    Wood E, Kerr T, Palepu A, Zhang R, Strathdee SA, Tyndall MW, Montaner JS, Hogg RS.
    J Infect; 2006 Apr 12; 52(4):233-6. PubMed ID: 16169594
    [Abstract] [Full Text] [Related]

  • 36. [Renal transplantation in HIV-infected patients in Spain].
    Mazuecos A, Pascual J, Gómez E, Sola E, Cofán F, López F, Puig-Hooper CE, Baltar JM, González-Molina M, Oppenheimer F, Marcén R, Rivero M.
    Nefrologia; 2006 Apr 12; 26(1):113-20. PubMed ID: 16649432
    [Abstract] [Full Text] [Related]

  • 37. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.
    AIDS; 2006 May 12; 20(8):1171-9. PubMed ID: 16691069
    [Abstract] [Full Text] [Related]

  • 38. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J.
    Clin Infect Dis; 2007 Oct 01; 45(7):925-32. PubMed ID: 17806063
    [Abstract] [Full Text] [Related]

  • 39. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L.
    HIV Med; 2007 May 01; 8(4):213-9. PubMed ID: 17461848
    [Abstract] [Full Text] [Related]

  • 40. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
    Mussini C, Manzardo C, Johnson M, Monforte Ad, Uberti-Foppa C, Antinori A, Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C, Late Presenter Investigators.
    AIDS; 2008 Nov 30; 22(18):2461-9. PubMed ID: 19005269
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.